Most of the firm’s limited partners are traditional institutional investors, including university endowments, private foundations, financial institutions, sovereign wealth funds and U.S. pension plans.Finance, news, Blockchain Capital, Funds, Venture CapitalRead More

You might also be interested in reading Akero Therapeutic prices upsized stock offering of $350M.